Back
CG Oncology, Inc. Vs. Nebius Group NV Industry Stock Comparison
Buy
54
CGON
CG Oncology, Inc.
Last Price:
$67.45
Seasonality Move:
-8.87%
Buy
51
NBIS
Nebius Group NV
Last Price:
$108.86
Seasonality Move:
16.36%
Buy
54
CG Oncology, Inc. (CGON)
is a Buy
Is CG Oncology, Inc. a Buy, Sell or Hold?
-
The current CG Oncology, Inc. [CGON] share price is $67.48. The Score for CGON is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
-
CGON is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
51
Nebius Group NV (NBIS)
is a Buy
Is Nebius Group NV a Buy, Sell or Hold?
-
The current Nebius Group NV [NBIS] share price is $108.82. The Score for NBIS is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
-
NBIS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CGON Stock Price Chart
What is CG Oncology, Inc.'s stock price today?
-
The CG Oncology, Inc. share price today is $67.48Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CGON is experiencing slight buying pressure.
NBIS Stock Price Chart
What is Nebius Group NV's stock price today?
-
The Nebius Group NV share price today is $108.82Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NBIS is experiencing buying pressure, which is a positive indicator for future bullish movement.
CGON Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.27 | Buy |
| Relative Strength Index (14 RSI): | 61 | Buy |
| Chaikin Money Flow: | 310122 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (61.22 - 66.68) | Buy |
| Bollinger Bands (100): | (41.61 - 60.65) | Buy |
NBIS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1 | Buy |
| Relative Strength Index (14 RSI): | 52.24 | Buy |
| Chaikin Money Flow: | 13258215 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (94.12 - 116.9) | Buy |
| Bollinger Bands (100): | (86.58 - 107.22) | Buy |
CGON Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 65.86 | Buy |
| 20-day SMA: | 64.98 | Buy |
| 50-day SMA: | 58.96 | Buy |
| 200-day SMA: | 41.67 | Buy |
| 8-day EMA: | 66.16 | Buy |
| 20-day EMA: | 64.39 | Buy |
| 50-day EMA: | 59.45 | Buy |
| 200-day EMA: | 45.73 | Buy |
NBIS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 105.45 | Buy |
| 20-day SMA: | 108.76 | Buy |
| 50-day SMA: | 99.99 | Buy |
| 200-day SMA: | 89.14 | Buy |
| 8-day EMA: | 105.76 | Buy |
| 20-day EMA: | 106.36 | Buy |
| 50-day EMA: | 102.68 | Buy |
| 200-day EMA: | 86.85 | Buy |
CG Oncology, Inc. Earnings Growth & CGON Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.17 per share, an increase next quarter of $0.02 per share, a decrease this year of $0.32 per share, and an increase next year of $0.41 per share.
Nebius Group NV Earnings Growth & NBIS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.10 per share, an increase next quarter of $0.82 per share, a decrease this year of $0.72 per share, and an increase next year of $1.68 per share.
CG Oncology, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Nebius Group NV Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||